ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.283,62
0,20%
S&P 500
5.297,10
-0,21%
US Dollar vs BRL
5,1303
0,00%
Bitcoin
65.449,08
0,32%
Brent Oil
83,215
0,01%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. PTC Therapeutics Inc (PTCT)

  7. PTC Therapeutics Inc (PTCT) Notícias

PTCT

PTC Therapeutics (PTCT)

PTC Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PTCT
DataHoraFonteTítuloCódigoCompanhia
14/05/202408:30PR Newswire (US)PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™NASDAQ:PTCTPTC Therapeutics Inc
10/05/202418:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
07/05/202416:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/05/202409:00PR Newswire (US)PTC Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:PTCTPTC Therapeutics Inc
25/04/202417:05PR Newswire (US)PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:PTCTPTC Therapeutics Inc
23/04/202417:30PR Newswire (US)PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PTCTPTC Therapeutics Inc
11/04/202409:00PR Newswire (US)PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial ResultsNASDAQ:PTCTPTC Therapeutics Inc
28/03/202409:30PR Newswire (US)PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMANASDAQ:PTCTPTC Therapeutics Inc
19/03/202408:30PR Newswire (US)PTC Therapeutics Provides Key Regulatory UpdatesNASDAQ:PTCTPTC Therapeutics Inc
29/02/202418:05PR Newswire (US)PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PTCTPTC Therapeutics Inc
15/02/202410:00PR Newswire (US)PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PTCTPTC Therapeutics Inc
14/02/202417:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PTCTPTC Therapeutics Inc
14/02/202409:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTCTPTC Therapeutics Inc
25/01/202418:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTCTPTC Therapeutics Inc
25/01/202418:05PR Newswire (US)CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination ProcedureNASDAQ:PTCTPTC Therapeutics Inc
08/01/202411:26PR Newswire (US)PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PTCTPTC Therapeutics Inc
03/01/202410:00PR Newswire (US)PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PTCTPTC Therapeutics Inc
05/12/202319:24Dow Jones NewsPTC Therapeutics Gives Updates on Translarna Regulatory ActivitiesNASDAQ:PTCTPTC Therapeutics Inc
05/12/202318:15PR Newswire (US)PTC Therapeutics Provides Updates on Translarna™ Regulatory ActivitiesNASDAQ:PTCTPTC Therapeutics Inc
07/11/202318:16Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:PTCTPTC Therapeutics Inc
26/10/202317:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTCTPTC Therapeutics Inc
26/10/202317:05PR Newswire (US)PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial ResultsNASDAQ:PTCTPTC Therapeutics Inc
19/10/202309:00PR Newswire (US)PTC Therapeutics Announces Evrysdi® Royalty Agreement with Royalty Pharma for Up To $1.5 BillionNASDAQ:PTCTPTC Therapeutics Inc
16/10/202317:30PR Newswire (US)PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2023 Financial Results NASDAQ:PTCTPTC Therapeutics Inc
29/09/202308:29IH Market NewsFriday’s Wall Street Highlights: New Integrated, Nike, Tesla, Alphabet, and moreNASDAQ:PTCTPTC Therapeutics Inc
28/09/202321:12Dow Jones NewsStocks to Watch: Nike, Novo Integrated, PTC TherapeuticsNASDAQ:PTCTPTC Therapeutics Inc
28/09/202317:30PR Newswire (US)PTC Announces Further Strategic Prioritization and Associated Reduction in WorkforceNASDAQ:PTCTPTC Therapeutics Inc
15/09/202307:00PR Newswire (US)CHMP Delivers Opinion on Translarna™ for Conversion to Full AuthorizationNASDAQ:PTCTPTC Therapeutics Inc
07/09/202309:00PR Newswire (US)PTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient CommunityNASDAQ:PTCTPTC Therapeutics Inc
28/08/202309:00PR Newswire (US)PTC Therapeutics to Present Recent Data for Sepiapterin at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual SymposiumNASDAQ:PTCTPTC Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PTCT

Seu Histórico Recente

BIT
UC611H
Unicredit Bank
LSE
AA56
Citi Fun 25
TSX
MGA
Mega Uranium
BIT
UC4YBQ
Unicredit Bank
COIN
B1PEUR
AMEX
GLUR
Gabelli Global Utility a...
USOTC
SLGD
Scotts Liquid Gold (PK)
BIT
SISP5S
SG Issuer Societe Generale
BIT
UB25VN
UniCredit Bank
COIN
LIBREETH
Libre
EU
BEB157569141
Euronext VPU Public auct...
COIN
PHLEUR
USOTC
USAE
US Aerospace (CE)
USOTC
ELUXY
AB Electrolux (PK)
COIN
NFTYUSD
NFTY Token
COIN
2GIVEEUR
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados